340B Archives - Feldesman Tucker Leifer Fidell LLP

HRSA Updates Ryan White HIV/AIDS Program Policy on Care in Correctional Settings; 2018 RWHAP Update

Posted November 29, 2018 By Jason Reddish & Scott S. Sheffler & Filed Under: 340B, Blog, Federal Grants, Health Law, Ryan White

New guidance clarifies ability of RWHAP providers to partner with city, county, and local jails for HIV/AIDS care and… Read More

House Energy & Commerce Committee Seeks Answers from 340B Program Contract Pharmacies

Posted August 7, 2018 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

Read More

Recent Developments with Contract Pharmacies and Other 340B Updates

Posted July 6, 2018 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

On July 3^rd, the Health Subcommittee of the House Energy & Commerce Committee announced a hearing entitled, “Read More

340B Roundup: The Senate and White House Focus on the 340B Program; Manufacturer Oversight and Overcharge Penalties Delayed (Yet Again)

Posted May 23, 2018 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

The 340B program continues to garner the attention of Congress and the Trump Administration. In a recent flurry of activity, the Senate Health,… Read More

REMINDER TO FQHCs TO RECERTIFY!

Posted February 13, 2018 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law, pharmacy

Each year, as required by the 340B statute, the Office of Pharmacy Affairs (OPA) requires covered entities to recertify that they meet the 340B… Read More

Senator Cassidy (R-LA) Introduces 340B Legislation That Would Impose 340B Claims Identification Requirements on All Covered Entities and a Hospital Moratorium

Posted February 2, 2018 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

On January 16, 2018, Senator Cassidy (R-LA) introduced the bill, Helping Ensure Low-income Patients have Access to Care and Treatment (HELP Act).… Read More

House Energy and Commerce Committee Issues Report on Review of 340B Program and Recommends Potentially Significant Changes

Posted January 12, 2018 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

Three hearings before the House Energy and Commerce (E&C) Committee and its Oversight and Investigation Subcommittee Read More

Year End 340B Round-Up: Hospital Moratorium Legislation Introduced; Hospital Payment Cuts Take Effect After Suit Hits Snag but Congress May Intervene

Posted January 5, 2018 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

The closing months of 2017 saw a flurry of activity related to the 340B drug pricing program, both as a topic of legislative and regulatory… Read More

CMS Cuts Medicare Part B 340B Drug Reimbursement in Hospital Outpatient Departments by Nearly 30 Percent

Posted November 3, 2017 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

On November 1, 2017, the Centers for Medicare & Medicaid Services (CMS) finalized the Read More

Congress Seeks Information from 340B Covered Entities and Holds Hearing to Discuss How Covered Entities Use 340B Savings

Posted October 17, 2017 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

On October 11, 2017, the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee convened a hearing on the use of… Read More

Enforcement of Manufacturer Overcharge Penalty Rule Delayed Until July 1, 2018; HRSA Might Propose New Rule

Posted October 17, 2017 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

HRSA has finalized its proposal to delay enforcement of its final rule imposing civil monetary penalties (CMPs) on manufacturers that overcharge… Read More

HRSA Proposes to Delay Enforcement of Manufacturer Overcharge Penalty Rule Until July 1, 2018; Seeks Comment on Delay

Posted August 18, 2017 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

HRSA is proposing to delay enforcement of its final rule imposing civil monetary penalties on manufacturers that overcharge 340B program covered… Read More

CLIENT ALERT: 340B Database Offline August 15 to Mid-September; Plan Ahead NOW

Posted August 11, 2017 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

Covered entitles and 340B program stakeholders should prepare now for a disruption to the 340B Office of Pharmacy Affairs Information System (340B… Read More

Congress Holds Subcommittee Hearing on 340B Program; Legislative Action Likely

Posted July 18, 2017 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

The Oversight and Investigations Subcommittee of the House Energy and Commerce Committee convened a hearing today titled “Examining HRSA’s… Read More

HRSA Administrator Sigounas, OPA Director Pedley Address 340B Coalition Conference and Discuss Program Changes

Posted July 17, 2017 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

George Sigounas, Ph.D., delivered his first remarks to 340B Coalition conference-goers since assuming his role as Administrator of the Health… Read More

Medicare Proposes Massive Cuts to Reimbursement for Hospital-Administered 340B Drugs

Posted July 17, 2017 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

The Centers for Medicare and Medicaid Services (CMS) is poised to propose massive cuts to Medicare Part B reimbursement rates for hospitals and… Read More

FTLF’s 340B/ Pharmacy Attorneys Presenting at 340B Coalition Summer Conference, July 9 – 12, 2017

Posted July 7, 2017 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

Attorneys from FTLF’s 340B/ Pharmacy Practice Group will be presenting the following educational sessions during the Read More

Reported Executive Action on Drug Pricing Could Impact 340B Program and Contract Pharmacies

Posted June 28, 2017 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

According to multiple reports, the Trump Administration is preparing to issue an Executive Order designed to address high drug costs. One… Read More

State Medicaid Agencies Are Implementing Harmful 340B Drug Billing and Reimbursement Changes

Posted June 8, 2017 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law, Medicaid

All clients participating in the 340B Discount Drug Program (340B program) should watch carefully for state changes to Medicaid reimbursement for… Read More

HRSA Delays Implementation of Manufacturer Penalty Enforcement…Again

Posted June 5, 2017 By Elizabeth J. Karan & Jason Reddish & Michael B. Glomb & Filed Under: 340B, Blog, Health Law

HRSA has announced that its regulations authorizing the imposition of civil monetary penalties (CMPs) on manufacturers that overcharge 340B… Read More

1

2

→